Indore-based surgeon Mohit Bhandari to receive prestigious International Surgeon Award at American Society for American Society for Metabolic and Bariatric Surgery (ASMBS); all you need to know about him
Mohit Bhandari
BHOPAL: Dr Mohit Bhandari, a surgeon based in Indore, Madhya Pradesh, is set to receive the prestigious International Surgeon Award at the upcoming American Society for Metabolic and Bariatric Surgery (ASMBS) Global Congress in Washington D.C.
, scheduled from 15 to 19 June 2025.
The award is regarded as one of the highest global honours in the field of metabolic and bariatric surgery.
Dr Bhandari has been chosen for this international recognition due to his development of the Self-Forming Magnetic Anastomosis Technique, an innovative surgical method that enhances safety, simplifies the procedure, and improves the effectiveness of bariatric surgeries.
This technique is especially helpful for patients with extreme obesity (weighing 200 kg or more), who are often not considered suitable for traditional surgical methods.
Having performed a record number of bariatric surgeries — claimed to be the highest in Asia — Dr Bhandari has significantly contributed to advancements in this medical field.
He has also introduced modern, non-surgical weight loss techniques in India, including Endoscopic Sleeve Gastroplasty (ESG) and the Allurion Balloon. His achievements have earned him a place in the World Book of Records.
'This award is not just a personal milestone but a recognition of India's growing expertise and research in advanced medical science,' claims Dr Bhandari.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
7 hours ago
- Time of India
Weight-loss surgery more effective than drugs in real world study
London: Bariatric surgeries led to about five-times more weight loss than weekly injections of popular GLP-1 drugs , according to data from a real-world comparison study presented on Tuesday at the American Society for Metabolic and Bariatric Surgery scientific meeting in Washington. "Clinical trials show weight loss between 15% to 21% for GLP-1s, but this study suggests that weight loss in the real world is considerably lower even for patients who have active prescriptions for an entire year," study leader Dr. Avery Brown of NYU Langone Health said in a statement. Researchers reviewed records of 38,545 patients who were prescribed injectable semaglutide or tirzepatide between 2018 and 2024 and 12,540 patients who underwent bariatric surgery during the same period. Everyone started the study with a body mass index of at least 35, which is considered severe obesity. Semaglutide is the main ingredient in Novo Nordisk 's Wegovy and Ozempic, while tirzepatide is the main ingredient in Eli Lilly 's Zepbound and Mounjaro. At three years after undergoing sleeve gastrectomy or gastric bypass or starting the drugs, patients who underwent surgery had lost on average 24% of their starting weight, compared to about 5% for similar patients who used the drugs for at least six months and about 7% for those who took them for a year. Brown noted that as many as 70% of GLP-1 patients may discontinue treatment within one year. "While both patient groups lose weight, metabolic and bariatric surgery is much more effective and durable," ASMBS President Dr. Ann M. Rogers, who was not involved in the study, said in a statement. "Those who get insufficient weight loss with GLP-1s or have challenges complying with treatment due to side effects or costs, should consider bariatric surgery as an option, or even in combination," she said. NEW BLOOD TEST MAY REDUCE LIVER TRANSPLANT FAILURES An experimental blood test can help surgeons catch and identify problems with newly transplanted livers at early stages, researchers say. It's not unusual for transplanted organs and recipients' nearby tissues to sustain damage during the transplantation process. Hints of problems will show up later in routine blood tests, but identifying the precise site of the damage often requires costly imaging studies and surgical biopsies, according to a report published on Tuesday in Nature Communications. The new test works by picking up DNA fragments left behind in the blood by dying cells. The chemical signatures on these DNA fragments can be used to identify the original cell type and where it came from, with precise detail, the researchers found. If you can determine which part of the liver is injured - for example, the bile ducts, or the blood vessels - "you could provide a more personalized treatment approach that leads to better care for the patient," study leader Dr. Alexander Kroemer of MedStar Georgetown University Hospital in Washington, DC said in a statement. In addition to being faster and less invasive than a traditional biopsy, the blood test is also potentially more accurate, because biopsies only sample a few spots in the liver and might miss the site of the problem, he added. Georgetown has filed patent applications on the technology, and the research team is seeking partners to commercialize the test. DIABETES PRECURSOR SHOWS UP ON MUSCLE ULTRASOUND Ultrasound exams of thigh or shoulder muscles can detect insulin resistance at its earliest stages, researchers reported in the Journal of Ultrasound in Medicine. "We perform a large number of shoulder ultrasounds and noticed that many patients' muscles appear unusually bright," study leader Dr. Steve Soliman of the University of Michigan said in a statement. His team discovered in earlier studies that most of these patients have type 2 diabetes. But some had bright muscles on ultrasound even with no signs of diabetes or prediabetes. Subsequently, upon short-term follow-up, these patients often also developed prediabetes or type 2 diabetes. To test the potential for noninvasive muscle ultrasound as a predictive tool for detecting the development of pre- or type 2 diabetes - potentially earlier than current methods - the researchers performed muscle ultrasounds on 25 patients who were also being evaluated for insulin resistance. Although muscle ultrasound could detect insulin resistance and impaired insulin sensitivity, in this small study the level of brightness was not directly correlated with the degree of the condition. The researchers are recruiting more participants to continue the analysis. The exact reason why muscle brightness on ultrasound might indicate insulin resistance is less clear than the finding that it does, the researchers said. "Clinicians increasingly use these point-of-care and handheld ultrasound devices, sometimes called 'the stethoscope of the future,' for rapid diagnosis of various conditions," Soliman said. "A medical assistant or clinician with little to no training could easily use this device on a patient's upper arm or thigh, as routinely as checking weight or blood pressure, and potentially flag patients as 'high risk' or 'low risk' for further testing."
Indian Express
17 hours ago
- Indian Express
Mounjaro, Wegovy result in lower weight loss in the real world than clinical trials, says study: What explains this gap?
At a time when makers of weight loss drug Mounjaro are claiming that you can lose up to 22.5 per cent of your starting body weight over 72 weeks on its highest dose of 15 mg, a new study says the reality is quite the opposite. Researchers found that people on weight loss injectables shed fewer pounds in the real world than in clinical trials. In other words, this study indicates these drugs may not produce drastic weight loss in everyday settings. Researchers analysed data from 51,085 patients with a body mass index of 35 or greater and who were eligible for weight loss surgery and weight loss jabs. The team compared the three-year weight loss journey in 38,545 people prescribed semaglutide (sold under brand name Wegovy) and tirzepatide (Mounjaro) with 12,540 patients who underwent weight loss surgery. They found that those who underwent bariatric surgery had a significantly higher weight loss after two years, at 26.5%, compared with 5.7% for those prescribed semaglutide and tirzepatide. Semaglutide is a GLP1 receptor agonist (RA) which mimics the GLP 1 hormone and helps control blood sugar, reduce appetite and accelerate weight loss. Tirzepatide (Mounjaro) is a GLP1-RA cum GIP agonist. GIP has a role in food metabolism. The study will be presented at the American Society for Metabolic and Bariatric Surgery 2025 annual scientific meeting. 'The average patient on [GLP-1 RAs] in the real world is not getting the weight loss that we see in clinical trials,' says senior author Dr Karan Chhabra, Assistant Professor of Surgery & Population Health at Grossman School of Medicine, New York University. Does that mean that bariatric surgery will continue to be relevant? Listen in. 1) What could have been the reason for this discrepancy between weight loss in clinical trials and during real-time use of the drug? Though you have not done a data analysis on causes, what do you think went wrong? I think many patients either discontinued treatment or were not titrated (a method of assessing the concentration of a substance) up to the high doses needed for maximal weight loss. 2) Does this mean that we still need widespread studies on GLP 1 RAs? We need more real-world studies of GLP1 agonists – this study shows us that the clinical trial results do not always apply to real-world patients. Our team will be looking at this topic next – what can prescribers do to maximize the effectiveness of GLP1 RAs. 3) So far makers of weight loss drugs had claimed that their drugs were almost equivalent to bariatric surgery. How does this study challenge that perception? This study shows that in real world conditions, these drugs lead to far lesser weight loss than bariatric surgery for the average patient. 4) Who needs bariatric surgery? Rather, which set of people are more likely to benefit from bariatric surgery? Ultimately the treatment strategy should be tailored to individual patients' characteristics and preferences. Patients who do not want to be on lifelong medications, or who need 20 per cent weight loss to achieve their health goals, or who do not have insurance coverage for GLP1 RAs would be better served with surgery. 5) Do you see weight loss drugs having long-term efficacy? Weight loss drugs are effective for maintaining weight loss only for as long as they are taken. Many studies show that patients regain as much as 70 per cent of the weight lost when they stop taking these drugs. 6) Are weight loss drugs more hype than effect? No, this study underscores that these drugs are not a silver bullet but they can be highly effective when prescribed carefully by an expert physician. The goal is to get as many people to the right treatment (for obesity) as possible.
Time of India
2 days ago
- Time of India
BJ Medical College blaze: Nanny's presence of mind saves doctor's 2-year-old daughter after AI 171 crash
Nanny Takes Charge Child Was First to Be Rescued Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel A two-year-old girl was saved from a dangerous fire at the BJ Medical College hostel building in Ahmedabad, thanks to her mother's instinct and her nanny's quick actions. The fire had broken out after the crash of Air India flight AI 171 on to a TOI report, Dr Chanchal Bhandari, a cardiac anaesthetist at the UN Mehta Institute of Cardiology and Research Centre (UNMICRC), received a call from her daughter's nanny saying that smoke was coming from their building. Without wasting time, she rushed back home on her scooter, only to be stopped at the campus gate as rescue teams battled the Bhandari said it was the nanny's quick thinking that saved her daughter. 'She immediately took my daughter to a higher floor to avoid the smoke. When the rescue team asked her to come down, she carefully climbed down one floor while keeping my daughter safe from the smoke,' she to the heavy smoke and flames, residents were told to jump down onto a rescue mat. 'My baby's skin had turned black because of the smoke,' Dr Bhandari said, holding back tears. Her daughter was the first to be caught safely in the mat, followed by the nanny.'I'm thankful to God and to my nanny for saving her,' she child is now under observation and stable at the Civil Hospital campus, according to from TOI
